stockportfolio.pro
Stocks / KMTS vs PNTG
KMTS vs PNTG
Kestra Medical Technologies, Ltd. and The Pennant Group, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Kestra Medical Technologies, Ltd. (KMTS) | The Pennant Group, Inc. (PNTG) | |
|---|---|---|
| Market cap | $1.2B | $1.1B |
| Revenue (latest FY) | $59.81M | $947.71M |
| Net income (latest FY) | $-113.81M | $29.58M |
| Revenue growth (5y CAGR) | 180.0% | 19.4% |
| Net margin | -190.3% | 3.1% |
| Return on equity | -55.4% | 8.9% |
| P/E ratio | — | 37.6 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 9 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open KMTS — free Open PNTG — freeFrequently asked questions
Which is bigger, KMTS or PNTG?
Kestra Medical Technologies, Ltd. is larger by market capitalization — $1.2B versus $1.1B.
Which grows faster, KMTS or PNTG?
Over the last five fiscal years, Kestra Medical Technologies, Ltd. grew revenue faster — 180.0%/yr versus 19.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.